Breaking News Instant updates and real-time market news.

WMT

Walmart

$94.92

0.09 (0.09%)

, TGT

Target

$87.72

0.45 (0.52%)

10:30
09/18/18
09/18
10:30
09/18/18
10:30

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Walmart (WMT) initiated with an Outperform at BMO Capital while Target (TGT) was initiated with a Market Perform. 2. Apache (APA) initiated with an Overweight at Stephens. 3. Supernus (SUPN) initiated with a Buy at Mizuho. 4. Transocean (RIG) initiated with a Buy at BTIG. 5. Noble initiated with a Neutral at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

WMT

Walmart

$94.92

0.09 (0.09%)

TGT

Target

$87.72

0.45 (0.52%)

APA

Apache

$46.69

0.91 (1.99%)

SUPN

Supernus

$47.80

1.85 (4.03%)

RIG

Transocean

$11.93

0.335 (2.89%)

NE

Noble Corp.

$6.21

0.25 (4.19%)

  • 19

    Sep

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

  • 01

    Oct

  • 28

    Oct

  • 15

    Nov

  • 27

    Nov

  • 03

    Mar

WMT Walmart
$94.92

0.09 (0.09%)

09/14/18
GSCO
09/14/18
DOWNGRADE
Target $101
GSCO
Neutral
Walmart reinstated with a Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Matthew Fassler reinstated coverage of Walmart with a Neutral rating and $101 price target. This is a downgrade from the Buy rating the analyst had on the shares prior to going to Not Rated in January. Fassler likes the positioning and execution of the company's core U.S. business which, but feels this is largely priced into the shares at current valuation levels. Further, he believes Walmart's commitment to reinvesting in its e-commerce capabilities creates less upside potential to his EBIT forecasts.
09/17/18
BMOC
09/17/18
INITIATION
Target $110
BMOC
Outperform
Walmart initiated with an Outperform at BMO Capital
BMO Capital analyst Kelly Bania initiated Walmart with an Outperform and $110 price target.
09/07/18
BMOC
09/07/18
DOWNGRADE
Target $90
BMOC
Market Perform
Dover downgraded to Market Perform at BMO Capital on refrigeration end-market
As reported earlier, BMO Capital analyst R. Scott Graham downgraded Dover (DOV) to Market Perform from Outperform and lowered his price target to $90 from $93 citing valuation as the stock price has risen about 18% since mid-June. The analyst also says that he is increasingly concerned about the refrigeration end-market - about 17% of the company's sales - amid the structural changes in the food retailing industry, as the "non-traditional" grocers take market share from traditional ones. Graham notes that the initiatives by Amazon (AMZN) and Walmart (WMT) are accelerating the capex shifts in that industry.
09/18/18
BMOC
09/18/18
INITIATION
Target $110
BMOC
Outperform
Walmart initiated with an Outperform at BMO Capital
As reported earlier, BMO Capital analyst Kelly Bania initiated Walmart with an Outperform rating and a price target of $110, citing the company's "significant investments in infrastructure and 3rd party marketplace" that should position it for long-term e-commerce profitability. The analyst believes that investors will start to exclude the expected near-term e-commerce losses related to the Flipkart deal and U.S. investments in their valuation, which she expects to peak this year.
TGT Target
$87.72

0.45 (0.52%)

09/17/18
BMOC
09/17/18
INITIATION
BMOC
Market Perform
Target initiated with a Market Perform at BMO Capital
09/18/18
BMOC
09/18/18
INITIATION
Target $88
BMOC
Market Perform
Target initiated with a Market Perform at BMO Capital
As reported earlier, BMO Capital analyst Kelly Bania initiated Target with a Market Perform rating and a price target of $88. The analyst cites her expectations of a flat EBIT margin pressured by the "digital fulfillment cost headwinds and wage costs" that may outweigh the company's improvements in its supply chain. Bania adds that Target valuation of 15-16-times forward earnings - slightly above historical average of 14-times - may be pressured as a result relative to its discrount store peers.
08/29/18
WELS
08/29/18
NO CHANGE
Target $118
WELS
Outperform
Dollar General price target raised to $118 from $113 at Wells Fargo
Wells Fargo analyst Edward Kelly raised his price target for Dollar General (DG) to $118 from $113 ahead of quarterly results. The analyst notes that expectations seem high given the 23% increase in the stock since last quarter's weather-related disappointment. While Kelly expects solid results and raised his estimates accordingly, he cautions investors not get carried away as retailers with high consumable exposure like Dollar General may not see the acceleration produced by Walmart (WMT) and Target (TGT). The analyst reiterates an Outperform rating on Dollar General's shares as the demand backdrop looks supportive of strong results through a massive low-income refund cycle in early 2019.
08/23/18
08/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ROSENBLATT BOOSTS AMD PRICE TARGET TO STREET HIGH: Rosenblatt analyst Hans Mosesmann raised his price target for AMD (AMD) shares to $30 from $27. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard. AMD is up 4.1% in late morning trading. CANTOR CUTS AETNA TO NEUTRAL: Cantor Fitzgerald analyst Steven Halper downgraded Aetna (AET) to Neutral from Overweight with a price target of $202. The stock now trades at just a 4.6% discount to the implied CVS Health (CVS) acquisition value of about $207 per share, Halper said. He believes the narrowed deal spread reflects an increased likelihood of regulatory approval. Halper cites limited potential upside for his downgrade of Aetna to Neutral. NIELSEN UPGRADED TO NEUTRAL AT GOLDMAN: Goldman Sachs analyst George Tong upgraded Nielsen Holdings (NLSN) to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model. Nielsen is up 3.3% in late morning trading. IMPERIAL SEES SUBSCRIBER UPSIDE FOR NETFLIX: Imperial Capital analyst David Miller believes Netflix's (NFLX) experiment with ending billing through Apple's (AAPL) app store in 33 countries outside the U.S. likely implies upside to its Q3 international subscriber guidance. The analyst said he has a tough time believing that Netflix would "experiment" with billing infrastructure mid-quarter if it did not believe that its international subscriber levels were trending ahead of guidance. As such, Miller raised his Q3 international subscriber estimate to 4.46M from 4.35M. He kept an Outperform rating on Netflix with a $494 price target. TARGET GETS UPGRADE AND DOWNGRADE: Target (TGT) was upgraded to Outperform from Market Perform at Telsey Advisory, and downgraded to Peer Perform from Outperform at Wolfe Research.
APA Apache
$46.69

0.91 (1.99%)

09/17/18
SPHN
09/17/18
INITIATION
Target $52
SPHN
Overweight
Apache initiated with an Overweight at Stephens
Stephens analyst Gail Nicholson initiated Apache with an Overweight rating and $52 price target, stating that she believes the market is mispricing the value of its Altus Midstream joint venture and significant growth potential from Alpine High. One investor pushback on Apache has been lack of free cash flow generation, but Nicholson forecast approximately $1.9B of positive cash flow generation from 2019-2022, she tells investors.
08/07/18
MUFG
08/07/18
NO CHANGE
Target $66
MUFG
Overweight
Apache price target raised to $66 from $60 at MUFG
MUFG analyst Michael McAllister raised his price target for Apache to $66 after the company reported production within the U.S. rose 10% sequentially for Q2. Year-over-year production growth in the region came in at 32%, and for the second time this year U.S. results have driven guidance higher, McAllister tells investors in a post-earnings research note. The analyst keeps an Overweight rating on Apache shares.
09/18/18
EDJN
09/18/18
DOWNGRADE
EDJN
Hold
Apache downgraded to Hold from Buy at Edward Jones
09/18/18
09/18/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fortinet (FTNT) downgraded to Neutral from Buy at UBS with analyst Fatima Boolani saying the company's momentum appears priced into the shares at current levels. 2. United Continental (UAL) downgraded to Neutral from Outperform at Macquarie with analyst Susan Donofrio citing valuation. 3. Workiva (WK) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Stan Zlotsky saying the stock is the best performer of all stocks covered by the firm's Software team given its 50% move up over the last three months, which he attributes to heightened investor expectations, the near-term benefits from an extremely strong period within capital markets, and enthusiasm about the new CEO. 4. Discovery (DISCA) downgraded to Sell from Hold at Pivotal Research with analyst Brian Wieser saying despite "tepid" earnings and "underwhelming" longer-term trends, the stock is up 20% over the past month. 5. Apache (APA) downgraded to Hold from Buy at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SUPN Supernus
$47.80

1.85 (4.03%)

09/18/18
MZHO
09/18/18
INITIATION
Target $61
MZHO
Buy
Mizuho starts Supernus with Buy rating, $61 price target
Mizuho analyst Irina Koffler last night initiated coverage of Supernus Pharmaceuticals with a Buy rating and $61 price target. The company, with a "promising" pipeline that can drive growth through pending Trokendi XR competition in migraine, is well positioned in an attractive market, Koffler told investors in a research note.
09/17/18
MZHO
09/17/18
INITIATION
Target $61
MZHO
Buy
Supernus initiated with a Buy at Mizuho
Mizuho initiated Supernus with a Buy and $61 price target.
07/02/18
PIPR
07/02/18
NO CHANGE
Target $47
PIPR
Neutral
Piper sees 'more tepid sales growth trajectory' for Supernus
Piper Jaffray analyst David Amsellem says that while his survey of 25 neurologists did not necessarily suggest that Supernus Pharmaceuticals' (SUPN) migraine prophylaxis treatment Trokendi XR will see pressure due to the availability of Amgen's (AMGN) Aimovig, there were data points that suggest Trokendi's volume growth "could slow meaningfully. 64% of respondents have patients with either moderate or significant difficulty with insurance coverage when trying to get a Trokendi XR prescription filled, Amsellem tells investors in a research note. He sees a "more tepid sales growth trajectory" for Trokendi XR going forward and reiterates a Neutral rating on Supernus with a $47 price target.
08/28/18
PIPR
08/28/18
NO CHANGE
Target $44
PIPR
Neutral
Supernus current risk/reward not favorable, says Piper Jaffray
After surveying 25 neurologists who currently prescribe Supernus Pharmaceuticals' Oxtellar XR in epilepsy, Piper Jaffray analyst David Amsellem believes the eventual label expansion for the drug as monotherapy for partial seizures, expected before year-end, is unlikely to drive a major uptick in prescription volume growth. Notably, a significant majority of respondents to the survey already use Oxtellar XR as monotherapy, Amsellem tells investors in a research note. The analyst continues to caution against drawing parallels between the Oxtellar XR monotherapy opportunity and Trokendi XR in migraine prophylaxis. Amsellem does not believe the current risk/reward profile is favorable on Supernus shares and keeps a Neutral rating on the name with a $44 price target.
RIG Transocean
$11.93

0.335 (2.89%)

09/05/18
UBSW
09/05/18
NO CHANGE
Target $15
UBSW
Buy
Transocean deal for Ocean Rig the right strategic move, says UBS
UBS analyst Sasha Sanwal believes Transocean's (RIG) acquisition of Ocean Rig DW ((ORIG) materially increases the company's upside to a recovery at a fair valuation that is in line to slightly below recent deals. Although there is some pushback on near-term dilution to 2019 estimates, he believes the deal offers a favorable mix of upside for 2020 from future rig activations and higher backlog balanced by a desire to limit stress on the balance sheet and liquidity. Sanwal reiterated his Buy rating and $15 price target on Transocean shares.
09/04/18
JPMS
09/04/18
NO CHANGE
JPMS
Transocean acquisition unlikely to attract new shareholders, says JPMorgan
JPMorgan analyst Sean Meakim says that while Transocean's (RIG) acquisition of Ocean Rig UDW (ORIG) aligns well with its strategy and should be received well by current investors, the deal is unlikely to attract incremental shareholders. The move also highlights the financial constraints of Transocean's peers Ensco (ESV) and Noble Corp. (NE), leaving it positioned as the "last man standing" as a consolidator, Meakim tells investors in a research note. The analyst, however, keeps an Underweight rating on Transocean given his bearish view on pricing. He does not see immediate accretion from Ocean Rig on valuation alone.
08/09/18
LEHM
08/09/18
DOWNGRADE
Target $5
LEHM
Underweight
Barclays calls offshore drillers overvalued, downgrades Noble to Underweight
Barclays analyst J David Anderson downgraded Noble Corp. (NE) to Underweight from Neutral while raising his price target for the shares to $5 from $4. Since March, offshore-themed drilling stocks have outperformed on the back of Brent oil prices moving above $70 per barrel, Anderson tells investors in a research note. However, current share prices now imply day rates will eclipse $400,000 per day by mid-2022 "in the face of substantial floater overcapacity and few signs of an imminent recovery," the analyst adds. As such, he believes the offshore drillers are the most overvalued group in his coverage. Anderson sees 27% average downside from current levels and downgrades Noble to Underweight. He keeps Underweight ratings on Diamond Offshore (DO), Ensco (ESV), Rowan Companies (RDC) and Transocean (RIG).
09/17/18
BTIG
09/17/18
INITIATION
Target $18
BTIG
Buy
Transocean initiated with a Buy at BTIG
BTIG analyst Gregory Lewis initiated Transocean with a Buy rating and a price target of $18 as part of his broader research note on offshore drilling service industry, saying the company is his "top pick" in the space. The analyst notes that Transocean has a "dominant offshore footprint" and the "largest rolodex" in the business, benefiting from the momentum of the industry recovery. Lewis also expects Transocian to be a "major beneficiary as activity in Brazil and West Africa picks up," anticipating the company to capture more of the new business that its peers.
NE Noble Corp.
$6.21

0.25 (4.19%)

08/14/18
ARGS
08/14/18
UPGRADE
ARGS
Hold
Noble Corp. upgraded to Hold from Sell at Argus
09/17/18
BTIG
09/17/18
INITIATION
BTIG
Neutral
Noble initiated with a Neutral at BTIG
BTIG analyst Gregory Lewis initiated Noble with a Neutral rating as part of his broader research note on offshore drilling service industry, saying the company looks "fairly valued" at 17-times forward EBITDA even though it offers "the best fleet on the water" with a mix of premium Floaters and Jackups. The analyst adds that the stock has shrugged off the risk of potential litigation from Paragon bondholders, and its near term focus is with winning floater work while also positioning its rigs effectively.
08/14/18
ARGS
08/14/18
UPGRADE
ARGS
Hold
Noble Corp. upgraded to Hold from Sell at Argus
Argus analyst David Coleman upgraded Noble Corp to Hold from Sell on "improving industry fundamentals", saying the company is seeing better fleet utilization and day rates while also winning new contracts. The analyst further cites Noble CEO Julie Robertson stating that the offshore drilling industry is benefiting from higher crude oil prices and also sees the prospects of improvement in the company's operating environment in spite of its "relatively weak balance sheet". Coleman also points to Noble's price to book valuation multiple of 0.3-times, which is near the low end of its 5-year 0.1-1.1-times historical range.

TODAY'S FREE FLY STORIES

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.71

0.25 (0.49%)

17:11
02/15/19
02/15
17:11
02/15/19
17:11
Hot Stocks
Oracle authorizes additional $12B stock buyback under existing program »

In a regulatory 8K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

SBLK

Star Bulk Carriers

$8.21

0.13 (1.61%)

17:03
02/15/19
02/15
17:03
02/15/19
17:03
Hot Stocks
Star Bulk Carriers acquires 95,605 of its common shares »

Star Bulk Carriers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$20.56

0.26 (1.28%)

17:02
02/15/19
02/15
17:02
02/15/19
17:02
Earnings
Hollysys reports Q2 adjusted EPS 73c, consensus 59c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

AKS

AK Steel

$2.98

-0.015 (-0.50%)

16:58
02/15/19
02/15
16:58
02/15/19
16:58
Syndicate
Breaking Syndicate news story on AK Steel »

AK Steel files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
02/15/19
02/15
16:55
02/15/19
16:55
General news
Treasury Market Summary: i »

Treasury Market Summary:…

LPTX

Leap Therapeutics

$1.65

(0.00%)

16:53
02/15/19
02/15
16:53
02/15/19
16:53
Hot Stocks
Valence Helix Investments discloses 10.99% stake in Leap Therapeutics »

Valence Helix disclosed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$23.25

-0.24 (-1.02%)

16:52
02/15/19
02/15
16:52
02/15/19
16:52
Hot Stocks
Mid Penn Bancorp seeks approval to relocate Allentown Boulevard branch »

Mid Penn Bank, subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$423.79

8.54 (2.06%)

, AMGN

Amgen

$188.31

1.6 (0.86%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
Regeneron says EPO revokes Immunex's European patent No. 2,990,420 »

Regeneron…

REGN

Regeneron

$423.79

8.54 (2.06%)

AMGN

Amgen

$188.31

1.6 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 28

    Apr

  • 13

    May

UPS

UPS

$110.89

-0.91 (-0.81%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
UPS CFO sells 9.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

DAL

Delta Air Lines

$51.09

0.58 (1.15%)

16:43
02/15/19
02/15
16:43
02/15/19
16:43
Syndicate
Breaking Syndicate news story on Delta Air Lines »

Delta Air Lines files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$110.89

-0.91 (-0.81%)

16:42
02/15/19
02/15
16:42
02/15/19
16:42
Hot Stocks
UPS raises quarterly dividend to 96c per share from 91c »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.